AOPEP and early-onset autosomal dominant Alzheimer disease: Recently, a new and potentially important therapeutic role for APO in the treatment of Alzheimer’s disease (AD) has been suggested; APO seems to stimulate Aβ catabolism, thus reducing the rate of Aβ oligomerisation and consequent neural cell death.